The Transmembrane Anterior Posterior Transformation 1 (TAPT1) gene performs multiple biological functions including organelle function regulation and bone development while also participating in cilia formation and signal transduction. Mutations in this gene result in serious bone defects and developmental abnormalities that mimic the symptoms of osteogenesis imperfecta. TAPT1 has a role in extracellular matrix formation while controlling bone strength and elasticity. Mutations in TAPT1 cause abnormal bone development which results in lower bone density together with bone deformities and easy fractures similar to osteogenesis imperfecta (OI).
The primary cause of OI is the mutations in type I collagen genes COL1A1 and COL1A2. Future research into TAPT1's molecular mechanism will enable the creation of accurate treatment approaches for associated diseases. The TAPT1 gene produces a transmembrane protein which functions in intracellular protein transport as well as cilia formation and bone development.
Related Products
Osteogenesis Imperfecta (OI) Overview
Osteogenesis Imperfecta (OI) is an inherited bone disorder characterized by:
- Fragile bones that easily break
- Slow growth
- Joint looseness
- Blue sclerae (in some people)
- Abnormal tooth development (dentinogenesis imperfecta)
- Hearing loss (certain types)
OI is primarily caused by mutations in type I collagen (mutations in the COL1A1 and COL1A2 genes), but in recent years, studies have found that mutations in other genes, such as TAPT1, may also cause similar bone abnormalities.
Function of TAPT1 Gene
TAPT1 is a gene encoding a transmembrane protein that plays an important role in multiple physiological processes such as organelle function, bone development and cilia formation. Although the functional research of TAPT1 is still in progress, existing studies have revealed its indispensable role in various biological processes.
Fig 1. Visualization of the human TAPT1 protein model (Etich, J., et al. 2023).
Organelle Function and Protein Transport
The TAPT1 encoded protein functions in the endoplasmic reticulum as well as in the Golgi apparatus and lysosome to ensure the proper transport and breakdown of proteins inside the cell. The TAPT1 protein regulates how proteins move from the endoplasmic reticulum to the Golgi apparatus for proper processing and secretion. The involvement of TAPT1 in lysosome-mediated protein degradation processes influences both cellular autophagy functions and waste removal capabilities.
Bone Development and Osteoblast Function
The development of bones and cartilage heavily depends on the function of TAPT1. The function of TAPT1 includes the regulation of osteoblast differentiation and mineralization which supports normal bone growth and remodeling. TAPT1 influences the development of osteoblasts and chondrocytes through signaling pathway regulation during the conversion of cartilage tissue to bone.
Ciliary Formation and Signal Transduction
Many cells contain primary cilia which function as signal detectors that manage critical developmental signaling pathways including Hedgehog (Hh), Wnt, and TGF-β. The function of TAPT1 could influence ciliary protein delivery or maintain ciliary structure stability which results in the regulation of intercellular signaling. Deviation in ciliary signaling results in developmental issues of bones and nerves along with other organs which manifest as shortened limbs and facial structure anomalies.
Cell Polarity and Tissue Morphology Regulation
TAPT1 influences cell structure by controlling how cytoskeleton and transmembrane proteins distribute themselves. TAPT1 influences cell extension, migration and arrangement during growth phases to maintain normal organ and tissue morphology. The protein TAPT1 appears to interact with the Wnt/PCP signaling pathway which influences both embryonic development and cellular organization.
Possible Nervous System Functions
The function of TAPT1 in neurons involves the regulation of neuronal polarity and axon growth which impacts both brain development and sensory system formation. The presence of cognitive impairment and neurodevelopmental delays in patients with TAPT1 mutations indicates that TAPT1 might contribute to nervous system operations.
TAPT1 Mutations Cause Osteogenesis Imperfecta-like Disease
TAPT1 gene mutations lead to abnormal bone development and bone mineralization defects, which in turn show symptoms similar to OI, including:
| Severe bone malformations |
Abnormal bone development leads to short limbs, skeletal deformities and growth retardation. |
| Reduced bone density |
TAPT1 mutations affect the function of osteoblasts, reduce the normal deposition of bone matrix, and lead to bone fragility. |
| Ciliary abnormalities affect signal transduction |
TAPT1-related cilia defects may interfere with the Hedgehog (Hh) signaling pathway, which is essential for bone development. |
| Additional symptoms |
Some patients may also have abnormal neurodevelopment, facial deformities or other congenital defects. |
Inheritance of TAPT1-related OI
The TAPT1 mutations exhibit an autosomal recessive pattern of inheritance. People who have one copy of this mutation typically do not show symptoms. Disease manifestation occurs in offspring only when both parents transmit their copy of the TAPT1 mutation. The classic OI originates from mutations in COL1A1 or COL1A2 leading to type I collagen abnormalities while TAPT1-related OI affects different molecular bone formation pathways and does not cause type I collagen abnormalities.
Research and Treatment Outlook
Currently, there is no specific treatment for TAPT1-related OI, but potential treatment strategies include:
Bisphosphonate therapy: used to increase bone density and reduce fracture risk (such as pamidronate).
- Stem cell therapy: Research is exploring how to use bone marrow stem cells or osteoblasts to treat OI.
- Physical therapy and surgery: used to improve bone deformities and enhance muscle support.
TAPT1 Mutations Cause OI Disease
TAPT1 mutations do not represent the predominant cause of OI but their crucial function in bone development indicates that OI caused by TAPT1 mutations represents a distinct bone disorder with clinical signs that parallel those of traditional OI. Future research analyzing TAPT1's role in bone development could lead to innovative treatment approaches for this uncommon condition.
References
- Etich, J., et al. TAPT1-at the crossroads of extracellular matrix and signaling in Osteogenesis imperfecta. EMBO Molecular Medicine. 2023, 15(7): e17528.
- Symoens, S., et al. Genetic defects in TAPT1 disrupt ciliogenesis and cause a complex lethal osteochondrodysplasia. The American Journal of Human Genetics. 2015, 97(4): 521-534.
.
